| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/23/2009 | EP2135617A2 Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 12/23/2009 | EP2134843A1 Kunitz-type recombinant inhibitor |
| 12/23/2009 | EP2134355A2 Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions |
| 12/23/2009 | EP2134353A1 Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery |
| 12/23/2009 | EP2134352A2 Wnt compositions and methods of use thereof |
| 12/23/2009 | EP2134329A1 Composition and microsphere for controlled-release of exendin, and method of preparing the same |
| 12/23/2009 | EP2134173A2 Treatment of diseases characterized by inflammation |
| 12/23/2009 | EP2134165A2 Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone |
| 12/23/2009 | EP1748760B1 Superloaded liposomes for drug delivery |
| 12/23/2009 | EP1613302B1 Preserved and stable compositions containing peptide copper complexes and methods related thereto |
| 12/23/2009 | EP1483297B1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 12/23/2009 | EP1425295B1 Modified peptides and their use for the treatment of autoimmune diseases |
| 12/23/2009 | EP1421174B1 Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof |
| 12/23/2009 | EP1290028B1 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF |
| 12/23/2009 | EP1274861B1 Compositions and methods for identifying and targeting cancer cells |
| 12/23/2009 | EP1274726B1 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 12/23/2009 | CN201366104Y Externally-applied gynecological suppository with active protein and nano-silver |
| 12/23/2009 | CN101611320A Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (gp2) from zymogenic granules of the pancreas for the diagnosis of inflammatory intestinal diseases and chronic pan |
| 12/23/2009 | CN101611053A Anti-angiogenic compounds |
| 12/23/2009 | CN101611050A Pharmaceutically acceptable salts of Thymodepressin and processes for their manufacture |
| 12/23/2009 | CN101611039A HCV NS3 protease inhibitors |
| 12/23/2009 | CN101610784A PTH formulations and methods of use |
| 12/23/2009 | CN101610783A Therapeutic agent for spinal cord injury |
| 12/23/2009 | CN101610782A Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity |
| 12/23/2009 | CN101610781A Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 12/23/2009 | CN101610780A Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass |
| 12/23/2009 | CN101610759A Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs |
| 12/23/2009 | CN101608176A Tabanus yao fibrinogen hydrolase tabfiblysin, gene and application thereof |
| 12/23/2009 | CN101607992A Antibacterial peptide separated from cow blood and code sequence and application thereof |
| 12/23/2009 | CN101607990A Earthworm active protein, extraction method and application thereof |
| 12/23/2009 | CN101607984A Multi-copy polypeptide and application thereof |
| 12/23/2009 | CN101607913A 改进的螯合剂缀合物 Improved chelator conjugate |
| 12/23/2009 | CN101607080A Oral drug for treating diabetes and preparation method thereof |
| 12/23/2009 | CN101607079A Application of GLP-1 and analogue thereof in preparing medicine for treating Alzheimer's disease |
| 12/23/2009 | CN101606949A Rapid haemostat using mipor starch with high specific surface area as main raw material and preparation process thereof |
| 12/23/2009 | CN100572542C Systemic viral/ligand gene delivery system and gene therapy |
| 12/23/2009 | CN100572540C Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
| 12/23/2009 | CN100572527C Medium for culturing autologous human progenitor stem cells and applications thereof |
| 12/23/2009 | CN100572393C Dog interferon alpha preparation process and use thereof |
| 12/23/2009 | CN100572390C Inhibitor of stem cell proliferation and uses thereof |
| 12/23/2009 | CN100572389C BIM apoptosis effect minimum core sequence and its preparation and uses |
| 12/23/2009 | CN100571773C Method and composition for treating skin wounds with epidermal growth factor |
| 12/23/2009 | CN100571772C Use of integrin receptor alpha v beta 3 and /or alpha v beta 5 antagonist in preparing medicine for treating eye disease |
| 12/23/2009 | CN100571771C Use of repeated sequence protein polymers in personal care compositions |
| 12/23/2009 | CN100571715C Compositions containing bioactive materials, methods of preparation and treatment |
| 12/23/2009 | CA2852177A1 Glucagon/glp-1 receptor co-agonists |
| 12/23/2009 | CA2739610A1 Dna-directed customization of analgesic compounds as a therapeutic modality |
| 12/23/2009 | CA2735724A1 Compositions and methods for treating influenza |
| 12/23/2009 | CA2728763A1 Crkl targeting peptides |
| 12/23/2009 | CA2728669A1 Methods and compositions |
| 12/23/2009 | CA2728496A1 Cd5 pharmaceutical compositions for the treatment of infectious and inflammatory processes of fungal origin |
| 12/23/2009 | CA2728402A1 Apparatus and methods for controlling cellular development |
| 12/23/2009 | CA2728284A1 Glucagon/glp-1 receptor co-agonists |
| 12/23/2009 | CA2728268A1 Cdca1 epitope peptides and vaccines containing the same |
| 12/23/2009 | CA2728155A1 Combination of a tiliroside and a peptide |
| 12/23/2009 | CA2728131A1 Heat-stable, aqueous lactoferrin composition and its preparation and use |
| 12/23/2009 | CA2727862A1 Boronate ester compounds and pharmaceutical compositions thereof |
| 12/23/2009 | CA2727465A1 Improved peptide mediators of cholesterol efflux |
| 12/23/2009 | CA2727161A1 Glucagon analogs exhibiting enhanced solubility and stability physiological ph buffers |
| 12/23/2009 | CA2727147A1 Glycosylated glp-1 peptide |
| 12/23/2009 | CA2726281A1 Preparation and composition of inter-alpha inhibitor proteins from blood |
| 12/23/2009 | CA2726161A1 A peptide derivative and a composition for promoting lacrimal secretion comprising the same |
| 12/23/2009 | CA2724900A1 Bifunctional molecules for inhibiting hiv entry |
| 12/22/2009 | US7635769 Oligoribonucleotide derivatives for specific inhibition of gene expression |
| 12/22/2009 | US7635767 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same |
| 12/22/2009 | US7635766 Insulin-responsive DNA binding proteins-1 and methods to regulate insulin-responsive genes |
| 12/22/2009 | US7635763 Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use |
| 12/22/2009 | US7635758 Immunoglobulin for use in diagnosis of metabolic, glandular, cell proliferative, gastroitestinal amd reproductive disorders |
| 12/22/2009 | US7635757 Nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro |
| 12/22/2009 | US7635755 Free of organic solvents and wherein fibroin solution is produced by process comprising dialyzing aqueous silk fibroin solution against hygroscopic polymer for sufficient time to result in aqueous fibroin solution of at least 10 wt %, wherein hygroscopic polymer has a molecular weight of 8,000 g/mol |
| 12/22/2009 | US7635752 Ablated SLAM-Dependent Entry |
| 12/22/2009 | US7635751 For development of pharmaceutical preparations such as neutral nerve function regulator, circulatory function regulator, a cardiac function regulator, an immune function regulator, a digestive organ function regulator, metabolic function regulator |
| 12/22/2009 | US7635750 Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation |
| 12/22/2009 | US7635749 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 12/22/2009 | US7635694 Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 12/22/2009 | US7635684 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 12/22/2009 | US7635683 inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease |
| 12/22/2009 | US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 12/22/2009 | US7635680 Attenuation of reperfusion injury |
| 12/22/2009 | US7635679 A polypeptide variant of the human HMGB1 high affinity binding domain Box-A (HMGB1 Box-A); more favorable pharmacokinetic and pharmacodynamic profiles; diagnose, prevent, or treat pathologies associated with extracellular HMGB1 and associated with RAGE ( receptor for advanced glycation end products ) |
| 12/22/2009 | US7635678 Annexin V is used to prevent thrombosis without increasing hemorrhage; annexin binds to phosphatidylserine on outer surface of cell membranes, thereby preventing binding of prothrombinase complex necessary for thrombus formation |
| 12/22/2009 | US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/22/2009 | US7635676 Modified annexin proteins and methods for their use in organ transplantation |
| 12/22/2009 | US7635675 Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
| 12/22/2009 | US7635674 insulin and carrieres, a second pharmaceutical composition containing O-(3-piperidino-2-hydroxy-1-propyl)nicotinic amidoxime ( BGP-15) and carriers; prediabetic state, metabolic X-syndrome, insulin sensitivity, glucose tolerance, dislipidemia or diabetes mellitus |
| 12/22/2009 | US7635673 Gene expression inhibition via contacting with tyrphostin; liposomes; drug screening |
| 12/22/2009 | US7635576 CC-chemokine binding tick proteins |
| 12/22/2009 | US7635484 Clostridial peptide for preventing or reducing immunoresistance to botulinum toxin therapy in humans and/or other mammals |
| 12/22/2009 | US7635483 Enzymatically inactive streptococcal C5a peptidase (SCP) conjugated or linked to one or more peptides; effective in immunizing a susceptible mammal against beta-hemolytic Streptococcus |
| 12/22/2009 | US7635480 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis |
| 12/22/2009 | US7635479 comprising fusion protein biodrug as antitumor agent; contains amino acid sequence from prokaryotic organism such as a Listeria species protein, an ActA protein, a Streptolysin protein; immunotherapy |
| 12/22/2009 | US7635478 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/22/2009 | US7635475 Diabody-type bispecific antibody |
| 12/22/2009 | US7635474 VEGF-binding fusion proteins |
| 12/22/2009 | US7635471 Xylanase gene sequences from the genomic DNA of unpurified rumen microorganisms |
| 12/22/2009 | US7635470 Lysosomal enzyme for use in destroying clostridial bacteria in chesse and milk products; improving food processing |
| 12/22/2009 | US7635467 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 12/22/2009 | US7635466 treating human cancers or tumors with biodrug; amino acid sequences; viricides; anticarcinogenic agent |
| 12/22/2009 | US7635464 Selective targeting of apoptotic cells |
| 12/22/2009 | CA2627862C Use of inhibitors of dipeptidyl peptidase iv (dp iv) in combination with inhibitors of alanyl-aminopeptidase (apn) |